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Abstract
The influenza virus RNA polymerase complex is a heterotrimer composed of the PB1, PB2, and PA subunits. PB1, the catalytic
core and structural backbone of the polymerase, possesses four highly conserved amino acid motifs that are present among
all viral RNA-dependent RNA polymerases. A previous study demonstrated the importance of several of these conserved
amino acids in PB1 for influenza polymerase activity through mutational analysis. However, a small number of viruses
isolated in nature possesses non-consensus amino acids in one of the four motifs, most of which have not been tested for
their replicative ability. Here, we assessed the transcription/replication activities of 25 selected PB1 mutations found in
natural isolates by using minireplicon assays in human and avian cells. Most of the mutations tested significantly reduced
polymerase activity. One exception was mutation K480R, observed in several pandemic (H1N1) 2009 viruses, which slightly
increased polymerase activity relative to wild-type. However, in the background of the pandemic A/California/04/2009
(H1N1) virus, this mutation did not affect virus titers in cell culture. Our results further demonstrate the functional
importance of the four conserved PB1 motifs in influenza virus transcription/replication. The finding of natural isolates with
non-consensus PB1 motifs that are nonfunctional in minireplicon assays suggests compensatory mutations and/or mixed
infections which may have ‘rescued’ the inactive PB1 protein.
Citation: Chu C, Fan S, Li C, Macken C, Kim JH, et al. (2012) Functional Analysis of Conserved Motifs in Influenza Virus PB1 Protein. PLoS ONE 7(5): e36113.
doi:10.1371/journal.pone.0036113
Editor: Leo L. M. Poon, University of Hong Kong, Hong Kong
Received November 28, 2011; Published May 15, 2012
Copyright:  2012 Chu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Pfizer Animal Health Veterinary Science Scholars Program (http://www.avmf.org/whatwedo/pfizerscholarship/). The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: C.C. has received financial support from the Pfizer Animal Health Veterinary Science Scholars Program. G.N. was a consultant for
Theraclone and is a Co-Founder of FluGen. Y.K. has received speaker’s honoraria from Chugai Pharmaceuticals, Novartis, Daiichi-Sankyo, Toyama Chemical, Wyeth,
and GlaxoSmithKline; grant support from Chugai Pharmaceuticals, Daiichi Sankyo Pharmaceutical, Toyama Chemical, Otsuka Pharmaceutical Co., Ltd.; is
a consultant for Theraclone and Crucell, and is a Co-Founder of FluGen. This does not alter the authors’ adherence to all the PLoS ONE policies on sharing data
and materials.
* E-mail: kawaokay@svm.vetmed.wisc.edu (YK); neumanng@svm.vetmed.wisc.edu (GN)
¤ Current address: Department of Pharmaceutical Science, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, United States of America
. These authors contributed equally to this work.
Introduction
Influenza A viruses possess an RNA genome consisting of eight
single-stranded gene segments, each encoding at least one viral
protein [1]. In the virus particle, individual segments are
assembled into ribonucleoprotein (RNP) complexes that contain
viral RNA (vRNA) encapsidated by nucleoprotein (NP) and an
associated RNA-dependent RNA polymerase. As a heterocomplex,
the polymerase consists of three virus encoded polypeptides:
polymerase basic protein 1 (PB1), polymerase basic protein 2
(PB2), and polymerase acidic protein (PA). Upon infection, the
viral RNPs migrate into the host cell nucleus where negative-sense
vRNA serves as a template for synthesis of positive-sense
messenger RNA (mRNA) and complementary RNA (cRNA)
through the mechanisms of transcription and replication, re-
spectively [2]. Initiation of viral transcription requires 59-cap
primers generated from host cell pre-mRNAs [3]. Cap binding
and cleavage activities are performed by the viral polymerase
complex and depend on the interaction of the complex with the
vRNA template [4]. Polyadenylation of the viral mRNA
transcripts occurs by reiterative copying of an oligo(U) sequence
adjacent to the 59 terminus of each vRNA [5,6]. In addition, the
viral polymerase complex generates full-length, uncapped copies
of cRNA, which act as the replicative intermediate for production
of progeny vRNAs that are assembled into new virions [7].
While all three polymerase proteins are required for efficient
replication and transcription in virus-infected cells [8], PB1 plays
a central role in the formation of the structural backbone and
catalytic activities of the RNA polymerase [2,9]. It possesses four
highly conserved regions of amino acids (motifs I, II, III, and IV,
ranging in size from 4–13 amino acids) identified by comparative
sequence analysis of all viral RNA-dependent DNA polymerases
and RNA-dependent RNA polymerases [10,11]. Together, these
four conserved motifs form a large functional domain with at least
one ‘invariant’ amino acid per motif [11,12,13]. In a previous
study [10], these ‘invariant’ amino acids were tested for their
significance in polymerase activity in a minireplicon assay;
additional mutations were also introduced into the influenza viral
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polymerases of other RNA viruses. Most of these mutations
significantly reduced polymerase activity, demonstrating the
critical role of the conserved motifs in PB1 for influenza virus
transcription and replication [10]. However, our inspection of
influenza A virus PB1 sequences revealed a small number of PB1
proteins with non-consensus amino acids in the conserved motifs.
Currently, it remains unknown whether these PB1 proteins
support efficient viral replication and transcription of influenza
viral RNAs. Here, we therefore tested selected PB1 variants for
their replicative ability in minireplicon assays in cell culture. Our
data show that these amino acid changes may significantly
inactivate the polymerase, providing further support for the
importance of these four conserved PB1 motifs for influenza
polymerase activity.
Materials and Methods
Cell Culture
293T human embryonic kidney cells (obtained from ATCC)
and DF-1 chicken fibroblast cells (obtained from ATCC) were
maintained in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS). Calu-3 human
airway epithelial cells (obtained from Raymond Pickles, University
of North Carolina, Chapel Hill, NC) and Madin-Darby canine
kidney (MDCK, obtained from ATCC) cells were grown in
DMEM/F-12 [Nutrient Mixture F-12] supplemented with 10%
FBS and in minimal essential medium (MEM) containing 5%
newborn calf serum, respectively. Unless otherwise indicated, all
cell cultures were incubated at 37uCi n5 %C O 2.
Plasmid Construction
The construction of eukaryotic protein expression plasmids
pCAGGS/MCS [14] encoding for virus polymerase (PB2, PB1,
and PA) and NP proteins of A/bar-headed goose/Qinghai/1/
2005 (H5N1) was performed as previously described [15]. In brief,
full length cDNA of each polymerase and NP gene was generated
from extracted viral RNA (vRNA) by RT-PCR. Protein expression
plasmids were then constructed by cloning the entire cDNA into
the pCAGGS/MCS vector controlled by the chicken b-actin
promoter. PB1 mutant plasmids were generated by site-directed
mutagenesis PCR using primers containing the corresponding
alterations. All plasmid constructs were subsequently sequenced to
confirm the presence of the mutation of interest, and the absence
of unwanted mutations.
To assess the replicative ability of the viral polymerase complex
in human or avian cells, cDNA constructs transcribing virus-like
RNA that encodes the reporter protein luciferase were cloned
under the control of the human [16] or avian [17] RNA
polymerase I promoter, respectively.
For generation of recombinant influenza viruses, genes of the
A/California/04/2009 (H1N1) virus were cloned into an RNA
polymerase I (pol I)-driven plasmid, as described previously [16].
Briefly, cDNAs for the full-length viral RNAs of each gene were
amplified by PCR with primers containing BsmBI sites, incubated
with BsmBI, and cloned into the BsmBI-sites of pPol I vectors. In
these RNA polymerase I constructs, each gene is consequently
flanked by the human RNA pol I promoter and the mouse RNA
pol I terminator. All constructs were sequenced prior to use to
confirm the desired sequence.
Expression and Measurement of Luciferase Activity
Human 293T cells in 24-well culture plates were transfected
with virus polymerase protein expression plasmids (i.e., PB2, PA,
NP, and wild-type or mutant PB1, 0.1 mg each), along with the
luciferase reporter plasmid (0.02 mg) controlled by the human
RNA pol I promoter. As an internal control for the luciferase
assay, Renilla luciferase reporter plasmid pGL4.74[hRluc/TK]
(0.01 mg) (Promega, Madison, WI) was also cotransfected into cells
to normalize for transfection efficiency. At 24 h post-transfection,
cells were lysed and assessed for luciferase activity using the Dual-
Luciferase Reporter Assay System (Promega) and automated
application of the Infinite M1000 microplate reader (Tecan,
Switzerland) according to manufacturer’s instructions. Three
independent experiments were carried out, each performed in
triplicate. Luciferase activity levels were expressed as percentages
of the values observed for wild-type PB1.
Assays in avian cells were essentially carried out as described
above. Chicken DF-1 cells were transfected with the four protein
expression plasmids (0.25 mg each), the luciferase reporter plasmid
controlled by the avian RNA pol I promoter (0.05 mg), and
pGL4.74[hRluc/TK] (0.025 mg). DF-1 cells were incubated at
41uC for 24 h to accommodate for the higher body temperature of
chickens. Luciferase activities were determined as described above.
Quantitative Real-time RT-PCR
Human 293T cells in 6-well culture plates were transfected with
polymerase and NP protein expression plasmids (i.e., BHG/01-
pCAGGS-PB2, BHG/01-pCAGGS-PA, BHG/01-pCAGGS-NP,
and wild-type or mutant BHG/01-pCAGGS-PB1, 2 mg each),
together with an RNA transcription plasmid (polI-WSN-NP,
0.5 mg) controlled by the human RNA pol I promoter. Eight hours
later, cells were washed three times and incubated with Opti-
MEM medium. Forty-eight hours after transfection, cells were
harvested and lysed by direct addition of RLT buffer from the
RNeasy kit (QIAGEN), followed by RNA extraction and DNase
treatment to remove transfected plasmid DNA. The concentration
of purified RNA was determined by use of spectrophotometry.
Hot-start reverse transcription with specific primers for the
amplification of vRNA, cRNA, and mRNA was performed as
described by Kawakami et al. [18]. Quantitative PCR (qPCR) was
performed with SYBR Green qPCR SuperMix for ABI PRISM
(Invitrogen) on an ABI PRISM 7900HT cycler. For qPCR
amplification, samples were incubated for 10 min at 95uC,
followed by 40 cycles of 95uC for 15 s and 60uC for 1 min. The
amount of beta-actin mRNA served as internal control. The
relative concentrations of viral replication products were de-
termined by analysis of cycle threshold values, normalized to beta-
actin, and then calculated as percentages relative to the levels of
wild-type RNAs. Results represent the average levels of RNAs 6
standard deviations from one representative experiment carried
out in triplicate.
Western Blot Analysis
293T cells in 6-well culture plates were transfected with
plasmids expressing wild-type or mutant PB1 protein. Forty-eight
hours later, cells were collected, pelleted by centrifugation at
3,000 rpm for 5 min, lysed in RIPA buffer [25 mM Tris-HCl
pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate,
0.1% SDS, protease inhibitor cocktail tablets (Roche, Indianapo-
lis, IN)] for 20 min on ice, and spun down at 4uC for 15 min.
Supernatants were mixed with SDS loading buffer (160 mM Tris-
HCl, pH 6.8, 4% SDS, 20% glycerol, 10% 2-mercaptoethanol,
and 0.04% bromophenol blue) and blotted. PB1 protein and beta-
actin were detected with antibodies to the respective proteins
(available in our group or purchased from Sigma, St. Louis, MO,
respectively).
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Wild-type and mutant A/California/04/2009 (H1N1) viruses
were generated as previously described [16,19]. Briefly, 293T cells
were transiently transfected with eight RNA polymerase I plasmids
(0.1 mg each) expressing each of the influenza vRNA segments and
four pCAGGS/MCS plasmids (1 mg each) designed to express the
viral PB2, PB1, PA, and NP proteins. Viral supernatants were
harvested at 48 h post-transfection and amplified in MDCK cells
to produce viral stocks. The PB1 genes of stock viruses were
sequenced to rule out unwanted mutations. The titers of virus
stocks were determined by plaque assays in MDCK cells.
Replicative Properties of Viruses
Confluent monolayers of human Calu-3 cells were infected with
a multiplicity of infection (MOI) of 0.001 of virus. After 1 h
incubation, the cells were washed and further incubated in MEM/
F12 medium containing 0.3% bovine serum albumin and TPCK-
treated trypsin (0.4 mg/ml) at 35uC. Aliquots of supernatants were
harvested for virus titration every 12 h over an 84 h time course
post-infection: 12 h, 24 h, 36 h, 48 h, 64 h, 72 h, and 84 h. Virus
titers for each time point were determined by plaque assays in
MDCK cells.
Results
Influenza A Virus PB1 Proteins Possessing Non-consensus
Amino Acids in the Four Conserved Polymerase Motifs
Based on our analysis and information published by Biswas &
Nayak [10], we evaluated the following amino acid motifs in the
influenza virus polymerase protein PB1: motif I –
303TGDN
306;
motif II –
403LSPGMMMGMF
412; motif III
–
438WDGLQSSDDFALI
450; motif IV –
474GINMSKKKSYI
484
(see also Fig. 1A–D); these motifs are highly conserved among
influenza A virus PB1 proteins, while minor deviations exist for the
PB1 proteins of influenza B and C viruses. We inspected the Los
Alamos National Laboratory influenza database (http://www.flu.
lanl.gov/; sequences used in this research are available to the
public and can be requested by emailing flu@lanl.gov’’) and the
NIH NCBI (http://www.ncbi.nlm.nih.gov/genomes/FLU/FLU.
html) influenza database and identified ,235 mutations in the
conserved motifs of influenza A virus PB1 proteins (among
.14,000 PB1 proteins listed) (Table 1). The most frequently
observed deviation was K480R (motif IV), which was found in 33
human, 40 swine, and 15 avian virus PB1 proteins (i.e., in 0.45%,
4.21%, and 0.24% of the evaluated human, swine, and avian virus
PB1 proteins, respectively).
Comparison of the four conserved motifs revealed lower
variability in motifs I and II (14 and 29 mutations, respectively)
than in motif III (48 mutations) and motif IV (144 mutations, of
which 88 encode K480R, see above) (Table 1). Avian virus PB1
proteins show greater variability in the conserved motifs than
human virus PB1 proteins (Table 1), which can be traced to
a relatively high variability in the conserved PB1 domains of
viruses of the H5N1 and H9N2 subtypes (Table 2): for example,
50 of the 120 mutations (i.e. 42%) found in PB1 motifs I – IV map
to H5N1 viruses, although viruses of this subtype account for only
25% of the avian virus sequences in the database. Among human
influenza viruses, greater variability in PB1 motifs I-IV was found
among pandemic (H1N1) 2009 viruses as compared to seasonal
H1N1 or H3N2 viruses.
Past analyses also revealed one or two ‘invariant’ amino acids
per motif [10]. We identified two, one, seven, and seven PB1
proteins that do not encode the ‘invariant’ residues D305 (motif I),
G406 (motif II), D445/D446 (motif III), or K481 (motif IV),
Figure 1. Effects of mutations in the four conserved motifs of
PB1 on influenza polymerase activity. (A) Motif I; (B) Motif II; (C)
Motif III; (D) Motif IV. Consensus sequences are listed by motif with
numbers at each end indicating the position of the first and last amino
acid residue. Invariant amino acids are underlined. Selected mutations
found in the four conserved motifs of natural isolates (see Table 3)
were introduced into the PB1 protein of A/bar-headed goose/Qinghai/
1/2005 (H5N1) virus. The polymerase activity of each PB1 mutant was
assessed in human 293T cells by quantifying luciferase activity in the
cell lysates of cells transfected with PB1- (wild type or mutant), PB2-, PA-
and NP-protein expression plasmids along with a reporter plasmid
expressing an influenza virus-like RNA construct for luciferase.
Luciferase activity levels were normalized by the Renilla internal control
and expressed as a percentage relative to wild-type PB1 activity set as
100%. Data values are averaged over three independent transfection
experiments where each experiment was run in triplicate. Error bars
represent one standard deviation.
doi:10.1371/journal.pone.0036113.g001
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PB1 proteins (14 mutations), in contrast to only three and no
mutations in swine and human virus PB1 proteins, respectively.
Given the high degree of conservation for PB1 motifs I – IV,
multiple changes may be considered unlikely. Nonetheless, we
identified 22 PB1 proteins that possess more than one alteration in
one of the conserved motifs, and 10 PB1 proteins that possess
alterations in two motifs. Again, most of these proteins (19/22, and
7/10, respectively) are of avian virus origin.
Collectively, our analyses indicated that influenza A viruses with
alterations in the conserved polymerase motifs of PB1 are found in
nature.
Polymerase Complex Activity of Wild-type and Mutant
PB1 Proteins in Human Cells
To assess the replicative ability of PB1 proteins possessing non-
consensus amino acids, we selected 25 variants (Table 3) for
further testing. We focused on variants that occurred in more than
one virus isolate, highly pathogenic avian H5N1 viruses, at the
‘invariant’ positions in motifs III or IV (viruses with deviations at
the ‘invariant’ positions in motif I or II had not been reported at
the time variants were selected for testing), and/or were detected
in the PB1 proteins of viruses that crossed the species barrier, such
as (i) A/Guangxi/1/05, A/Indonesia/CDC292N/05, and A/
Indonesia/286H/06 (avian H5N1 influenza viruses isolated from
infected individuals), (ii) A/Thailand/271/05 (H1N1; a swine
influenza virus isolated from an infected person), and (iii)A /
swine/Anhui/ca/2004 (H5N1) and A/swine/Korea/S83/2004
(H9N2), both of which are avian influenza viruses that were
transmitted to pigs.
To determine the transcription/replication efficiency of wild-
type or altered polymerase complexes, we introduced the selected
changes into the PB1 segment of A/bar-headed goose/Qinghai/
1/2005 (H5N1; BHG) virus through site-directed mutagenesis.
This strain was chosen because it possesses consensus sequences at
all four conserved motifs, and is closely related to some of the
viruses in which several of the selected mutations were found [20].
To assess the replicative ability of wild-type and mutant PB1
proteins, we transfected human 293T cells with four plasmids
encoding BHG-PB2, -PA, -NP, and wild-type or mutant PB1
protein, and a virus-like RNA encoding the reporter luciferase.
The results obtained in three independent experiments (each
carried out in triplicate) are summarized in Fig. 1A–D and
Table 3. The polymerase activities of the BHG PB1 mutants
tested can be classified into five categories: (i) seventeen mutants
with no or residual activity (luciferase values less than 1%
compared to wild-type PB1); (ii) two with drastically reduced
activity (between 1 and 20%); (iii) three with moderately reduced
activity (between 21 to 60%); (iv) two with slightly reduced or
equivalent activity (between 61 to 100%), and (v) one with slightly
higher activity than wild type. Thus, most of the mutations tested
significantly decreased or completely eliminated the BHG poly-
merase activity in our assay, despite detection of the particular
amino acids in natural isolates. Notably, replacement of the
invariant amino acids D445 and D446 in motif III, and K481 in
motif IV, abolished polymerase activity entirely. In contrast,
mutation K480R (motif IV) slightly increased transcription/
replication activity relative to wild-type polymerase activity.
For selected mutants, we also carried out quantitative real-time
RT-PCR to assess the levels of vRNA, cRNA, and mRNA in
transfected 293T (Fig. 2). The K480R mutant yielded increased
levels of viral replication products compared to wild-type PB1; this
increase was even more pronounced than that detected in
luciferase assays. For the other mutants tested, the levels of viral
replication products overall correlated with the levels of luciferase
expression: the N306T and D439E mutants yielded reduced levels
of vRNA, cRNA, and mRNA, whereas the remaining mutants did
not catalyze the synthesis of appreciable amounts of viral
replication products. Taken together, these results suggested that
the conserved motifs in PB1 indeed play a significant role in the
replicative capability of the influenza polymerase complex.
To assess if the impaired replicative ability of some PB1
proteins resulted from reduced protein stability, we next
performed western blot analysis for PB1 mutants with signifi-
cantly reduced replicative ability (Fig. 3); the K480R mutant
was included as a second ‘positive control’ since it directed
Table 1. Influenza A virus PB1 proteins with mutations in the conserve motifs I – IV.
Origin
of PB1 Sequences evaluated PB1 proteins with mutations in
motif I motif II motif III motif IV Total
Human virus 7218 (49.6%*) 4 3 8 39 54 (23%*)
Avian virus 6188 (42.5%*) 8 19 36 57 120 (51%*)
Swine virus 950 (6.5%*) 2 3 3 48 56 (24%*)
Other origin 208 (1.4%*) 0 4 1 0 5 (2%*)
Total 14564 (100%) 14 29 48 144 235 (100%)
*Percentage of total changes.
doi:10.1371/journal.pone.0036113.t001
Table 2. Avian virus PB1 proteins with mutations in the
conserved motifs I – IV.
Virus
subtype
Sequences
evaluated PB1 proteins with mutations in
motif I motif II
motif
III motif IV Total
H5N1 1562 (25%*) 5 2 15 28 50 (42%*)
H9N2 774 (13%*) 0 4 9 15 28 (23%*)
H7Nx 626 (10%*) 1 1 1 1 4 (3%*)
H6Nx 663 (11%*) 1 1 1 5 8 (7%*)
All Other 2563 (41%*) 1 11 10 8 30 (25%*)
Total 6188 (100%) 8 19 36 57 120 (100%)
*Percentage of total changes.
doi:10.1371/journal.pone.0036113.t002
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be expressed stably. We found that the S444P and D445G
mutations rendered the protein unstable; however, other
mutations at position 445 (tested in combination with mutations
at position 446, or at positions 447 and 449) resulted in
detectable protein, suggesting that the nature of the amino acid
at this position is critical. The remaining mutants tested here
were detected by western blot analysis, indicating that their
polymerase activity (rather than their stability) was affected.
Polymerase Complex Activity of Wild-type and Mutant
PB1s in Avian Cells
In the experiments described above, we measured the
transcription/replication activity of wild-type and mutant avian
influenza virus polymerase proteins in human cells. Since the
replicative ability of influenza viral polymerase complexes can
differ significantly between avian and human cells [21,22], we next
carried out minireplicon assays in chicken cells (DF-1) using
a virus-like RNA synthesized from an avian RNA polymerase I
promoter [17]. Overall, we observed the same trends of poly-
merase activity (Table 3); however, two mutant PB1 proteins
(T303I and A448V) showed higher activity in chicken than in
human cells, while the inverse effect was observed for the D439E
and Q442L mutants. As detected in human 293T cells, mutant
K480R once again augmented transcription and replication
activity slightly. Taken together, these data argued against host-
specific effects for the PB1 mutants tested. Since DF-1 cells were
maintained at 41uC following transfection, these results also
Table 3. Mutations in the conserved motifs I – IV of the PB1 protein and their effects on replicative ability in human and chicken
cells.
Motif Mutation(s) Mutant BHG polymerase activity (%)
1
Virus(es) possessing the respective mutation(s)
Human cells Chicken cells
T303I 27.2 53.9 A/chicken/Taiwan/G2/87 (H6N1)
A/duck/HK/412/78 (H4N2)
I T303S 78.9 88.8 A/Guangxi/1/05 (H5N1)
N306T 2.4 0.8 A/Thailand/271/05 (H1N1)
II M409T 0 0.2 A/swine/Nordkirchen/IDT1993/03 (H3N2)
D439E 49.0 34.2 A/bar-headed goose/Qinghai/1/05 (H5N1)
A/whooper swan/Qinghai/01/05 (H5N1)
Q442L 19.2 6.2 A/duck/Vietnam/8/05 (H5N1)
A/duck/Vietnam/GZ-8/05 (H5N1)
A/Hong Kong/483/97 (H5N1)
Q442R/D445E/F447L 0 0.3 A/duck/Hubei/wq/03 (H5N1)
S444P 0 0.4 A/chicken/Anhui/1089/07 (H5N1)
III D445G 0 0.5 A/mallard/Yan chen/05 (H4N6)
D445S/D446S 0 0.3 A/swine/Doetlingen/IDT4735/2005 (H1N2)
D445C/F447V/L449I 0 0.3 A/chicken/Shantou/1126/01 (H9N2)
D446N 0 0.3 A/chicken/Guangdong/5/97 (H9N2)
A/chicken/Guangdong/10/00 (H9N2)
A/chicken/Jiangsu/1/00 (H9N2)
A448V 40.8 96.9 A/swine/Shanghai/1/07 (H1N2)
A/swine/North Carolina/93523/01 (H1N2)
I475V 67.6 73.1 A/Indonesia/CDC292N/05 (H5N1)
A/Queensland/60/05 (H3N2)
A/chicken/Taiwan/2838N/00 (H6N1)
N476Y 0 0.3 A/swine/Anhui/ca/04 (H5N1)
N476D 0 0.3 A/Indonesia/286H/06 (H5N1)
A/chicken/Taiwan/G2/87 (H6N1)
IV N476L/M477T 0 0.4 A/great black-headed gull/Qinghai/2/05 (H5N1)
N476T/S478T 0 0.3 Four 2005 H5N1 (Qinghai-Lake) isolates
2
S478T 0 0.3 Four 2005 H5N1 (Qinghai-Lake) isolates
2
S478R 0 0.2 A/swine/Guangxi/wz/04 (H5N1)
K480R 117.2 113.1 Several pandemic (2009) H1N1 viruses; several swine viruses
K481E 0 0.3 A/duck/Hunan/3340/06 (H5N1)
K481T 0 0.2 A/chicken/Hong Kong/873.3/01 (H5N1)
K481N 0 0.3 A/turkey/Israel/1567/04 (H9N2)
Y483H 0.5 0.3 A/swine/Korea/S83/04 (H9N2)
1The indicated mutations were introduced into the PB1 protein of A/bar-headed goose/Qinghai/1/2005 (H5N1; BHG) virus. Polymerase activity in human 293T and avian
DF-1 cells is indicated as percentage relative to wild-type PB1 activity.
2For some of these isolates, different sequences are reported in the Los Alamos National Laboratory and NIH NCBI databases.
doi:10.1371/journal.pone.0036113.t003
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temperature of chickens.
Polymerase Complex Activity and Virus Replication of
PB1-K480R in Pandemic H1N1 Virus Background
Among the 25 PB1 mutants tested, only K480R increased the
replicative ability of the BHG polymerase complex in minireplicon
assays. Interestingly, this mutation has been observed in several
early pandemic (H1N1) 2009 virus isolates. The K480R mutation
may have originated in pig influenza viruses, where it has been
found more frequently than in human and avian virus PB1
proteins. To assess its effects on the replicative ability of
a pandemic (H1N1) 2009 virus, we evaluated this mutation in
293T and DF-1 cells in the background of A/California/04/2009
(H1N1; CA04) virus, an early pandemic (H1N1) 2009 virus which
possesses consensus sequences at all four PB1 motifs. As found in
the background of BHG, the K480R mutation slightly increased
polymerase activities relative to wild-type in both cell lines (Fig. 4).
To further assess the significance of the K480R mutation for
virus replication, we generated wild-type CA04 virus and a mutant
encoding PB1-K480R. Human Calu-3 cells were infected with
a multiplicity of infection of 0.001 of wild-type or mutant virus,
and virus titers in the cell culture supernatant were measured at
several time points after infection. Both viruses replicated in Calu-
3 cells with similar kinetics (Fig. 5), and no difference in plaque
characteristics was observed. Sequence analysis of the PB1 gene
isolated from mutant viruses after replication in Calu-3 cells
indicated that the K480R mutation was maintained in the viral
population. Therefore, despite slightly enhanced polymerase
activity in the minireplicon assays, the K480R mutation did not
significantly affect the replication of a pandemic (H1N1) 2009
virus in human airway epithelial cells.
Discussion
Based on analysis of currently available sequences in influenza
databases, influenza viruses with non-consensus amino acids in the
four conserved motifs of PB1 protein exist in nature, although rare
in number. To assess the replicative ability of these PB1 proteins,
we evaluated their transcription/replication in minireplicon assays
and found that most of these PB1 mutations abolished polymerase
functionality (Table 3 and Fig. 1A–D). Our data support the
Figure 2. Quantitative analysis of vRNA, cRNA, and mRNA
levels for wild-type and mutant PB1 proteins. 293T cells were
transfected with plasmids expressing PB2, PA, NP, and wild-type or
mutant PB1 protein, along with a plasmid transcribing a viral RNA. The
levels of vRNA, cRNA, and mRNA were assessed by quantitative RT-PCR
and compared to those obtained with wild-type PB1 protein. The
results shown represent the average levels of RNAs 6 standard
deviations from a representative experiment carried out in triplicate. As
a negative control (Mock), the PB1 protein expression plasmid was
omitted.
doi:10.1371/journal.pone.0036113.g002
Figure 3. Western blot analysis of wild-type and mutant PB1 proteins. 293T cells were transfected with plasmids expressing wild-type or
mutant PB1 protein. Western blot analysis was carried out with antibodies to PB1 and beta-actin (control).
doi:10.1371/journal.pone.0036113.g003
Figure 4. Effects of PB1 mutation K480R on influenza poly-
merase activity in human and avian cells. The effects of PB1
mutation K480R were evaluated in the background of the A/California/
04/09 (H1N1) virus replication complex in human 293T and chicken DF-
1 cells. The experiments were carried out as described in the legend to
Figure 1. Luciferase activity levels were normalized by the Renilla
internal control and expressed as a percentage relative to wild-type PB1
activity in the particular cell line. *P,0.07 by Student’s t-test.
doi:10.1371/journal.pone.0036113.g004
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motifs are critical for replication and transcription. More
importantly, our results raise the question of how viruses with
these mutations exist in nature. The PB1 mutants tested exhibited
similar polymerase activities in both the human and avian cells,
arguing against host-specific effects. Therefore, a possible expla-
nation for the existence of natural isolates with PB1 mutations that
abrogate polymerase activity in our test system is the presence of
compensatory mutations acquired by the respective viruses. These
compensatory mutations may localize to the PB1 protein, and/or
to other components of the viral replication complex (i.e., PB2,
PA, or NP). Additionally, some of the PB1 mutants tested here
were found in viruses not closely related to the model strain used
(A/bar-headed goose/Qinghai/1/2005; H5N1; BHG). Hence,
the respective mutations may not be active in the genetic
background of BHG, but function in their authentic backgrounds.
Additional experiments would be needed to address this issue.
Furthermore, mixed populations of viruses may have been
sampled in which a virus with a mutant, nonfunctional PB1
protein was ‘rescued’ by a coinfecting virus with a functional PB1
gene/protein. Finally, we cannot rule out the possibility that
erroneous sequences were submitted to influenza sequence
databases.
Interestingly, mutation K480R in motif IV of the PB1
subunit consistently demonstrated slightly increased polymerase
activity in H5N1 and H1N1 polymerase complexes relative to
wild-type (Table 3, and Figs. 1A–D, 2 and 4). The amino
acid alteration at this position is considered conservative since
lysine and arginine are basic amino acids that share similar
chemical structures. As this mutation has been found in several
early pandemic (H1N1) 2009 virus isolates, we used reverse
genetics to introduce the K480R mutation into the PB1 subunit
of the A/California/04/09 (H1N1; CA04) virus strain to assess
viral growth characteristics. Although the K480R mutation
yielded increased amounts of replication products (Fig. 2) and
slightly increased replicative ability in the minireplicon assays
(Figs. 1 and 4), the mutation did not affect virus titers in cell
culture (Fig. 5). We have considered two likely possibilities to
explain the discrepancy in replication efficiency results between
the in vitro assays and growth curve analysis. While the K480R
mutation reproducibly enhanced transcription/replication in two
different polymerase backgrounds and in two different cell lines,
the observed increase (see Table 3 and Figs. 1A–D, 2 and 4)
may not be sufficient to translate into a detectable rise in virus
titer of the CA04 strain. Alternatively, the mutation in PB1 may
increase transcription/replication, but concomitantly interferes
with another step in the viral life cycle.
Structural data of the PB1 protein, along with the rest of the
heterotrimeric polymerase, may help in the interpretation of
mutational analysis of these four conserved motifs. To date, there
are no crystal structures available of the central region of the PB1
subunit in which the consensus motifs are found [23,24]. However,
based on secondary structure predictions, the ‘invariant’ amino
acids are frequently located within or proximal to turn structures
that may be crucial for their proper positioning in processes such
as cation binding and template specificity [11]. Considering the
‘invariant’ amino acids are embedded in blocks of conserved
residues, it is conceivable that the four motifs work cooperatively
to form a well-defined functional unit constituting the polymerase
module [10,11]. Therefore, intermotif distances may also be
critical for polymerase functionality by providing the correct
folding and three-dimensional structure of the protein. Once
detailed structural information of the PB1 subunit becomes
available, structure-function analysis may help to further elucidate
features of primary sequence or potential secondary structures of
the four conserved PB1 motifs that contribute to influenza
polymerase activity.
Despite lack of functional information on the individual
conserved PB1 motifs of the influenza virus, sequence comparison
and structural analysis of other RNA and DNA dependent viruses
suggest motif III as the core of the transcriptase-replicase activity
[10]. This motif is defined by a centrally located SDD consensus
sequence for influenza viruses (versus GDD in most other viral
polymerases). Common among all RNA-dependent RNA poly-
merases, the two ‘invariant’ aspartic acid residues are flanked by
hydrophobic residues and located in the turn of a beta-turn-beta
supersecondary structure [10,11,12,13]. Consequently, motif III
has been implicated in several functions including metal and
phosphate binding, template recognition, and other catalytic
functions. Our minireplicon assay results support the concept of
motif III as a key functional domain, as any mutation altering the
SDD sequence rendered the polymerase nonfunctional (Table 3
and Fig. 1A–D). We found that mutations S444P and D445G
rendered the protein unstable (Fig. 3), suggesting a structural role
for the amino acids at these positions. However, protein stability
(but not functionality) was maintained by serine or cysteine
residues at position 445, possibly in combination with additional
mutations nearby. Collectively, these findings indicate that the
highly conserved SDD motif is critical for protein stability and
functionality.
Our analysis of publicly available PB1 sequences suggests that
mutations in PB1 motifs I – IV occur more often in avian virus
PB1 proteins than in human or swine virus PB1 sequences (with
the exception of the K480R mutation which is frequently found in
swine virus PB1 proteins). Among avian virus PB1 proteins, more
mutations are found in the PB1 proteins of H5N1 and H9N2
viruses than in those of other subtypes (Table 2). Viruses of the
H5N1 and H9N2 subtypes circulate in poultry, in which influenza
viruses are known to mutate at higher rates than in aquatic birds
[25]. Thus, the relatively high rate of H5N1 and H9N2 viruses
with mutations in PB1 motifs I – IV may reflect the evolution of
Figure 5. Growth characteristics of wild-type virus and virus
possessing the PB1 K480R mutation. Wild-type A/California/04/09
virus and recombinant virus possessing the K480R mutation were used
for infection of human Calu-3 cells (MOI=0.001). Supernatants were
collected at specified time points following infection, and virus titers
were quantified by plaque assays in MDCK cells. Results shown are
averages of three plaque assays.
doi:10.1371/journal.pone.0036113.g005
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I – IV may render the polymerase complex more error-prone.
In summary, we have carried out a comprehensive analysis of
non-consensus amino acids in the four conserved motifs of PB1.
Although the mutations tested were reported in natural isolates,
most of them abolished polymerase activity, possibly suggesting
mixed virus populations and/or the presence of compensatory
mutations in the respective isolates. In addition, our study provides
more information on the PB1 amino acids critical for catalytic
function of the influenza polymerase complex. Such conserved
residues comprising the polymerase module may serve as potential
targets for anti-influenza drugs that can attenuate infection by
inhibiting influenza polymerase activity and thereby, virus
replication.
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